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Abstract: 
 
Objective: To examine how the time from HIV testing to care referral and from referral to care 
linkage influenced time to care engagement for newly diagnosed HIV-infected adolescents. 
 
Methods: We evaluated the Care Initiative, a care linkage and engagement program for HIV-
infected adolescents in 15 US clinics. We analyzed client-level factors, provider type, and 
intervals from HIV testing to care referral and from referral to care linkage as predictors of care 
engagement. Engagement was defined as a second HIV-related medical visit within 16 weeks of 
initial HIV-related medical visit (linkage). 
 
Results: At 32 months, 2143 youth had been referred. Of these, 866 were linked to care through 
the Care Initiative within 42 days and thus eligible for study inclusion. Of the linked youth, 
90.8% were ultimately engaged in care. Time from HIV testing to referral (eg, ≤7 days versus 
>365 days) was associated with engagement [adjusted odds ratio = 2.91; 95% confidence 
interval (CI): 1.43 to 5.94] and shorter time to engagement (adjusted hazard ratio = 1.41; 95% 
CI: 1.11 to 1.79). Individuals with shorter care referral to linkage intervals (eg, ≤7 days versus 
22–42 days) engaged in care faster (adjusted hazard ratio = 2.90; 95% CI: 2.34 to 3.60) and more 
successfully (adjusted odds ratio = 2.01; 95% CI: 1.04 to 3.89). 
 
Conclusions: These data address a critical piece of the care continuum and can offer suggestions 
of where and with whom to intervene to best achieve the care engagement goals outlined in the 
US National HIV/AIDS Strategy. These results may also inform programs and policies that set 
concrete milestones and strategies for optimal care linkage timing for newly diagnosed 
adolescents. 
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Article: 
 
INTRODUCTION 
 
The purpose of this paper is to examine factors associated with the time required for adolescents 
to engage in HIV-related care after HIV testing. The development and scale-up of youth-focused 
intensive case-management and patient navigation services over the past 10 years has markedly 
improved initial entry into HIV care, although up to 30% of adolescents are not promptly linked 
to care after initial diagnosis.1 Moreover, longer term treatment—including antiretroviral 
treatment (ART)—rarely begins before the second or subsequent visits. The time to ART 
initiation is critical, because earlier viral suppression improves an individual's HIV health 
outcomes and drastically reduces HIV transmission risk.2–7 Despite its importance in 
the HIV continuum of care, little information exists to identify factors associated with time to 
engagement that can guide program or service planning to achieve these goals, particularly for 
adolescents. Specifically, there has been little focus on modifiable factors that contribute to the 
interval between HIV testing and care engagement. 
 
Engagement refers to the maintenance of HIV-related health care after initial linkage, as 
demonstrated by an individual's motivation and readiness to attend a second HIV-related care 
appointment within a defined interval after linkage.8,9 This is reflected in the HIV Medicine 
Association guidelines that highlight how the “emphasis should be placed on the importance of 
adherence to care rather than focusing solely on adherence to medications”.10 The interval 
between HIVtesting and engagement in care requires necessarily prior events such as a youth's 
receipt of positive test results, referral to care, and initial receipt of HIV-related services (eg, 
medical, social, psychological). In contemporary usage, these early events in the continuum of 
care collectively represent care linkage.9,11 
 
Failures in timely care engagement may be especially important for adolescents as this age group 
constitutes 26% of new infections and approximately 60% of HIV-infected 13- to 24-year olds 
are undiagnosed.1,12,13 Once diagnosed and linked to care, nearly one-third of adolescents drop 
out of care.1,14,15 Adolescents consequently have lower rates of viral suppression and higher 
virologic rebound than adults: Only 6% of adolescents achieve initial viral suppression compared 
with 28% of HIV-infected adults.1,14 Engagement is therefore an important point in the 
continuum of care because the full benefits of modern biomedical interventions—prevention of 
advanced disease, reduced transmission risk, and reduced community viral load—are enacted as 
part of sustained engagement in care.16,17 Little research, however, has examined factors that 
influence the timeliness of engagement in care. 
 
This paper examines social and behavioral factors associated with time to engagement in care for 
newly diagnosed HIV-infected adolescents. These data inform understanding of a critical 
juncture in the HIV care continuum and suggest approaches to achieving the National HIV/AIDS 
Strategy's goal of “seamless” HIV care from HIV diagnosis to sustained viral suppression.7 
 
METHODS 
 
Data were collected from 15 Adolescent Medicine Trials Network (ATN) clinic sites. 
These Adolescent Medicine Trial Units (AMTU) care for adolescents, aged 12–24 years, in 13 
cities across the United States and Puerto Rico. The AMTUs are often the primary adolescent-
specific HIV care providers in their respective cities and also offer psychosocial services such as 
mental health, housing, and vocational support. Each AMTU implemented the SMILE Program 
in 2010. This initiative is a collaborative effort of NICHD, Centers for Disease Control and 
Prevention, and the ATN designed to facilitate linkage to care for adolescents with 
new HIV infection diagnoses. The initiative facilitated formal relationships among the AMTU, 
health departments, and local youth-serving organizations involved with HIV testing and 
treatment18and involved development of formal linkage to care protocols and provision of an 
outreach worker to facilitate linkage services, and to coordinate referrals within a given 
catchment area. The majority of referrals were assigned to the outreach worker, though some 
were assigned to other AMTU staff or community organizations. SMILE was designed to 
address the variable quality and fragmentation of services characteristic of youth HIV linkage to 
care activities in 2010. SMILE also emphasized the importance of formal relationships with the 
health departments intended to improve access to real-time HIV testing data. The criteria for 
referral to SMILE were similar across sites, with variation in referral patterns because of the 
variable success of facilitating linkages between the health department, AMTU, and local 
organizations. Linkage was defined as an HIV-related medical visit within 42 days (ie, 6 weeks) 
of referral; engagement was a second HIV-related medical visit within 16 weeks of the initial 
visit. These definitions reflect the intensive case-management approach adopted for the SMILE 
program and are more restrictive than standards for care linkage and engagement that came into 
wider use with adult patients after initiation of this study.8,19 The Institutional Review Board at 
each site approved all procedures. 
 
Independent Measures 
 
Independent measures included client-level factors and provider type. Client-level 
factors included youths' self-reported age, gender, race/ethnicity, sexual identity, homeless 
status, mode of HIV acquisition, and illicit drug use in the last year (eg, marijuana and heroin). 
The provider was the person assigned to provide linkage, categorized as the AMTU outreach 
worker, other AMTU staff (eg, physicians, nurses, case managers), or non-AMTU staff (eg, non-
AMTU clinic staff, community-based social worker). 
 
Outcome Measures 
 
We defined 2 intervals of importance for understanding care engagement. The first interval was 
the time in days between an individual's first positive HIV test and a second HIV-related clinic 
visit within 16 weeks of the first HIV-related clinic visit (care engagement). This diagnosis–
engagement interval provides insight into early factors (such as difficulty in locating patients for 
test results or because of inefficient referral networks) that could contribute to delays in receiving 
care. A second interval was time (in days) from referral to the SMILE program until a 
second HIV-related clinic visit within 16 weeks of an initial HIV-related clinic. This referral–
engagement interval variable provides program evaluation data and can be used to additionally 
refine standards of care for newly diagnosed HIV-infected youth. We also examined engagement 
as a dichotomous outcome, ie, whether an adolescent became engaged in care (or not) within 16 
weeks of an initial HIV-related visit. This variable serves as a quality of care standard.8,19 
 
Statistical Methods 
 
The proportional hazards regression analysis was used to examine the relationship of time from 
referral to engagement with potential impact factors such as age, gender, race/ethnicity, mode 
of HIV acquisition, client's housing status, drug use, case assignment status and time from 
referral to care linkage, and HIV testing to linkage. For those who engaged in care, the time was 
defined as the days from referral to the engagement (the second medical appointment). For those 
who were not engaged, we used days from referral to either the second medical appointment or 
the summation of lengths of referral to first medical appointment and half of 16 weeks after the 
first medical appointment. Covariates with an overall P-value of ≤0.20 were entered into the 
initial full multivariable model for model selection. The stepwise and backward model selection 
techniques were used to select the best final model. A similar analysis was performed for the 
outcome of time from HIV testing to engagement. To determine rates of engagement in care 
(no/yes), we used logistic regression analysis. All data analyses were run in SAS Version 9.3. 
 
RESULTS 
 
Description of Sample 
 
After 32 months, 2143 youth were referred to the SMILE program. Of these, 344 were excluded 
for having failed earlier linkage to care efforts (n = 106), having a prior positive test (n = 171) 
and perinatal route of infection (n = 67), leaving 1799 newly diagnosed cases referred to the 
SMILE program. Of these cases, 69.8% were linked to care, of which 89% were engaged in care; 
overall 62.1% of adolescents were linked to care and engaged in care. For the analyses in this 
paper, we additionally eliminated 145/1799 cases because they lacked an accurate test date (eg, 
missing year, testing date was in the future). Of the remaining 1655 cases, 866 were eligible for 
engagement in care because they completed an initial linkage to care visit within 42 days of 
referral. 
 
The study sample was predominantly men (80%), black (77%), and had acquired HIV through 
male-to-male sexual contact (74%). The mean age was 20.7 years, 66% reported drug use in the 
last year and most (80%) were assigned to an AMTU outreach worker (Table 1). 
 
Time From HIV Testing to Engagement in Care 
 
The unadjusted Cox model for time from HIV testing to engagement in care (Table 2) 
demonstrates that individuals who were referred and linked more quickly had a higher likelihood 
of care engagement, as did younger individuals, men, people who acquired HIV through male-to-
male sexual contact, and individuals assigned to other AMTU staff. Specifically, individuals who 
were referred to care within 365 days of being HIV tested had higher rates of care 
engagement than those who were referred after 365 days, though with a much greater effect size 
in the first 28 days compared with the rest of the first year. Individuals with shorter time intervals 
from referral to linkage were more likely to engage in care [hazard ratio (HR) = 1.36; 95% 
confidence interval (CI): 1.11 to 1.66]. Younger individuals also had a higher likelihood of 
engagement as did men (HR = 1.38; 95% CI: 1.13 to 1.67) versus women, HIV acquisition by 
male-to-male sexual contact (HR = 1.24; 95% CI: 1.04 to 1.48) versus different sex contact, and 
those who were assigned to other AMTU staff (HR = 1.51; 95% CI: 1.21 to 1.87) compared with 
an AMTU outreach worker. Ethnicity other than non-Hispanic white was associated with a lower 
likelihood of engagement. 
 
The adjusted Cox model showed that individuals with shorter intervals for referral and linkage to 
care were more likely to engage in care, as were non-white clients and those assigned to other 
AMTU staff. Shorter intervals from HIV testing to referral (<365 days compared with >365 
days) were much more likely to be engaged in care, though there is a decreasing magnitude of 
the trend as time from testing to referral lengthens. Individuals with shorter length from referral 
to linkage to care (<21 days compared with 22–42 days) also had greater likelihood of care 
engagement. Referral and linkage on the same day was not associated with engagement (Table 
2). Compared with non-Hispanic white individuals, non-Hispanic blacks, non-Hispanic others, 
and Hispanics were less likely to be engaged in care. Clients who were assigned to other AMTU 
staff compared with an outreach worker (HR = 1.29; 95% CI: 1.02 to 1.62) were more likely to 
have shorter engagement in care intervals. 
 
Time From Referral to Engagement in Care 
 
Factors related to interval from SMILE program referral to engagement in the unadjusted model 
also included clients who used drugs in the last 12 months (Table 3). Individuals referred to the 
SMILE program within 28 days of testing had a higher likelihood of being engaged in care than 
those referred after 1 year. Similarly, individuals linked to care on the same day as referral and 
within 21 days of referral had a higher likelihood of engagement in care than those linked 22–42 
days after referral. Clients who used drugs in the past 12 months (HR = 1.19; 95% CI: 1.02 to 
1.39) and individuals assigned to other AMTU staff (HR = 1.27; 95% CI: 1.03 to 1.58) compared 
with AMTU outreach workers were more likely to engage. Hispanics were less likely to be 
engaged in care (HR = 0.57; 95% CI: 0.41 to 0.81) compared with Non-Hispanic Whites. 
 
The results from the adjusted Cox model indicate that time from referral to linkage to care, time 
from HIV testing to referral, race/ethnicity, and mode of HIV acquisition were associated with 
engagement in care (Table 3). Subjects with a shorter time from HIV testing to referral (ie, <28 
days compared with >365 days) had an approximate 41%–69% increased likelihood of shorter 
time to care engagement. The length from referral to linkage to care showed that individuals 
linked more quickly (ie, in the first 3 weeks) were also more likely to engage in care than those 
linked within 22–42 days. Compared with non-Hispanic whites, Non-Hispanic Blacks, Non-
Hispanic Other, and Hispanics were less likely to be engaged in care. Individuals who reported 
acquiring HIV through male-to-male sexual contact had a shorter time to engagement in care 
than those who acquired HIV through heterosexual contact. 
Table 1. Demographic Characteristics Among All 886 HIV-Positive Adolescents 
 n (%) (N = 866) Mean (SD) 
Median 
(Minimum–
Maximum) 
Age (yrs), continuous 
12–17 
18–20 
21–22 
23–24 
Missing 
 
83 (9.63) 
301 (34.92) 
283 (32.83) 
195 (22.62) 
4 
20.68 (2.22) 21 (13-24) 
Gender 
Men 
Women 
Transgender 
Missing 
 
695 (80.35) 
148 (17.11) 
22 (2.54) 
1 
  
Race 
White 
Black 
American Indian/Alaskan Native 
Asian 
Mixed race 
Other 
Not asked/refused to answer 
 
87 (10.13) 
660 (76.83) 
2 (0.23) 
1 (0.12) 
70 (8.15) 
29 (3.38) 
10 (1.16) 
  
Ethnicity 
Hispanic 
Non-Hispanic 
Missing 
 
133 (15.48) 
729 (84.52) 
7 
  
Race/ethnicity 
Non-Hispanic white 
Non-Hispanic black 
Non-Hispanic other 
Hispanic 
Missing 
 
52 (6.08) 
635 (74.27) 
35 (4.09) 
133 (15.56) 
11 
  
Mode of acquisition 
Heterosexual contact 
Male-to-male sexual contact 
IDU + other 
Missing 
 
184 (21.27) 
641 (74.10) 
40 (4.62) 
1 
  
Time between HIV test date and referral to care initiative (d) 
0–7 
8–14 
15–28 
29–42 
43–60 
61–120 
121–180 
181–365 
365+ 
Missing 
 
286 (34.38) 
105 (12.62) 
104 (12.50) 
63 (7.57) 
49 (5.89) 
57 (6.85) 
20 (2.40) 
35 (4.21) 
113 (13.58) 
34 
178.30 (434.30) 17 (0–4089) 
What is the client’s current housing status: homelessness 
Yes 
No 
Not assessed (unknown)/other/refuse to answer/missing 
 
15 (1.97) 
745 (98.03) 
106 
  
Has the client used any of the drugs in the past 12 mo? 
Yes 
No 
 
572 (66.05) 
294 (33.95) 
  
Case assignment 
LTC OW 
Other AMTU staff 
Non-AMTU staff 
 
689 (79.65) 
111 (12.83) 
65 (7.51) 
  
Engaged in care 
Yes 
No 
 
786 (90.76) 
80 (9.24) 
  
Table 2. Relationship of Time From HIV Testing to Engagement-In-Care With Potential Impact Factors (Cox Model) 
 Total, n (%) EIC, n (%) No EIC, n (%) HR* (95% CI) P Adjusted HR (95% CI*) P 
Days from HIV testing to referral 
0–7 
8–14 
15–28 
29–365 
365+ 
 
286 (34.38) 
105 (12.62) 
104 (12.50) 
224 (26.92) 
113 (13.58) 
 
265 (92.66) 
99 (94.29) 
98 (94.23) 
2001 (89.73) 
94 (83.19) 
 
21 (7.34) 
6 (5.71) 
6 (5.77) 
23 (10.27) 
19 (16.81) 
 
123.44 (75.34 to 202.24) 
126.13 (74.12 to 214.63) 
91.17 (53.64 to 154.96) 
25.95 (15.80 to 42.63) 
1.00 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
 
155.19 (92.71 to 259.76) 
149.15 (86.01 to 258.64) 
117.68 (67.70 to 204.57) 
28.66 (17.13 to 47.95) 
1.00 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
Days from referral to LTC 
0 d 
1–7 
8–14 
15–21 
22–42 
 
114 (13.21) 
263 (30.48) 
189 (21.90) 
107 (12.40) 
190 (22.02) 
 
103 (90.35) 
242 (92.02) 
176 (93.12) 
97 (90.65) 
165 (86.64) 
 
11 (9.65) 
21 (7.98) 
13 (6.88) 
10 (9.35) 
25 (13.16) 
 
0.84 (0.66 to 1.09) 
1.36 (1.11 to 1.66) 
1.45 (1.17 to 1.80) 
1.25 (0.96 to 1.61) 
1.00 
 
0.1900 
0.0030 
0.0007 
0.0926 
 
1.21 (0.92 to 1.58) 
2.06 (1.67 to 2.54) 
1.82 (1.45 to 2.27) 
1.41 (1.09 to 1.84) 
1.00 
 
0.1727 
<0.0001 
<0.0001 
0.0097 
Age (yrs) 
12–17 
18–20 
21–22 
23–24 
 
83 (9.63) 
301 (34.92) 
283 (32.83) 
195 (22.62) 
 
81 (97.59) 
277 (92.03) 
255 (90.10) 
171 (87.69) 
 
2 (2.41) 
24 (7.97) 
28 (9.90) 
24 (12.31) 
 
2.05 (1.56 to 2.70) 
1.76 (1.44 to 2.15) 
1.33 (1.09 to 1.63) 
1.00 
 
<0.0001 
<0.0001 
0.0048 
  
Gender 
Men 
Women 
Transgender 
 
695 (80.35) 
148 (17.11) 
22 (2.54) 
 
627 (90.22) 
139 (93.92) 
20 (90.90) 
 
68 (9.78) 
9 (6.08) 
2 (9.10) 
 
1.38 (1.13 to 1.67) 
1.00 
0.89 (0.55 to 1.43) 
 
0.0012 
 
0.6208 
  
Race/ethnicity 
Non-Hispanic white 
Non-Hispanic black 
Non-Hispanic other 
Hispanic 
 
52 (6.08) 
635 (74.27) 
35 (4.09) 
133 (15.56) 
 
50 (96.15) 
580 (91.34) 
29 (82.86) 
119 (89.47) 
 
2 (3.85) 
55 (8.66) 
6 (17.14) 
14 (10.53) 
 
1.00 
0.79 (0.59 to 1.06) 
0.54 (0.34 to 0.86) 
0.79 (0.57 to 1.11) 
 
 
0.1156 
0.0087 
0.1797 
 
1.00 
0.52 (0.38 to 0.70) 
0.42 (0.26 to 0.68) 
0.48 (0.34 to 0.68) 
 
 
<0.0001 
0.0004 
<0.0001 
Mode of acquisition 
Heterosexual contact 
Male-to-male sexual contact 
IDU + other 
 
184 (21.27) 
641 (74.10) 
40 (4.62) 
 
171 (92.93) 
582 (90.80) 
32 (80.00) 
 
13 (7.07) 
59 (9.20) 
8 (20.00) 
 
1.00 
1.24 (1.04 to 1.48) 
1.12 (0.76 to 1.64) 
 
 
0.0154 
0.5731 
  
What is the client’s current housing status: homelessness 
Yes 
No 
 
15 (1.97) 
745 (98.03) 
 
14 (93.33) 
683 (91.68) 
 
1 (6.77) 
62 (8.32) 
 
0.83 (0.49 to 1.41) 
1.00 
 
0.4806 
  
Has the client used any of the drugs in the past 12 mo? 
Yes 
No 
 
572 (66.05) 
294 (33.95) 
 
522 (91.26) 
264 (89.80) 
 
50 (8.74) 
30 (10.20) 
 
1.09 (0.94 to 1.27) 
1.00 
 
0.2615 
  
Case assignment 
LTC OW 
Other AMTU staff 
Non-AMTU staff 
 
689 (79.65) 
111 (12.83) 
65 (75.15) 
 
631 (91.58) 
101 (90.99) 
53 (81.54) 
 
58 (8.62) 
10 (9.01) 
12 (18.66) 
 
1.00 
1.51 (1.21 to 1.87) 
1.05 (0.79 to 1.39) 
 
 
0.0002 
0.7381 
 
1.00 
1.29 (1.02 to 1.62) 
0.92 (0.68 to 1.24) 
 
 
0.0320 
0.5808 
*HR, hazard ratio. 
Table 3. Relationship of Time From Referral to Engagement-In-Care With Potential Impact 
Factors (Cox Model) 
 HR (95% CI) P Adjusted HR (95% CI) P 
Days from HIV testing to referral 
0–7 
8–14 
15–28 
29–365 
365+ 
 
1.41 (1.11 to 1.79) 
1.69 (1.27 to 2.26) 
1.49 (1.11 to 1.98) 
1.10 (0.85 to 1.41) 
1.00 
 
0.0048 
0.0003 
0.0069 
0.4681 
 
1.41 (1.11 to 1.80) 
1.66 (1.24 to 2.22) 
1.68 (1.24 to 2.26) 
1.12 (0.87 to 1.45) 
1.00 
 
0.0056 
0.0007 
0.0007 
0.3820 
Days from referral to LTC 
0 
1–7 
8–14 
15–21 
22–42 
 
1.58 (1.23 to 2.04) 
2.53 (2.06 to 3.11) 
2.03 (1.63 to 2.52) 
1.61 (1.24 to 2.08) 
1.00 
 
0.0004 
<0.0001 
<0.0001 
0.0003 
 
1.77 (1.36 to 2.30) 
2.90 (2.34 to 3.60) 
2.17 (1.73 to 2.72) 
1.64 (1.26 to 2.14) 
1.00 
 
<0.0001 
<0.0001 
<0.0001 
0.0003 
Age (yrs) 
12–17 
18–20 
21–22 
23–24 
 
1.21 (0.93 to 1.59) 
1.12 (0.92 to 1.36) 
0.93 (0.76 to 1.13) 
1.00 
 
0.1607 
0.2500 
0.4531 
  
Gender 
Men 
Women 
Transgender 
 
1.17 (0.97 to 1.41) 
1.00 
0.98 (0.61 to 1.57) 
 
0.1018 
 
0.9264 
  
Race/ethnicity 
Non-Hispanic white 
Non-Hispanic black 
Non-Hispanic other 
Hispanic 
 
1.00 
0.73 (0.54 to 0.98) 
0.58 (0.36 to 0.92) 
0.57 (0.41 to 0.81) 
 
 
0.0364 
0.0210 
0.0013 
 
1.00 
0.56 (0.42 to 0.77) 
0.45 (0.28 to 0.73) 
0.44 (0.31 to 0.62) 
 
 
0.0003 
0.0011 
<0.0001 
Mode of acquisition 
Heterosexual contact 
Male-to-male sexual contact 
IDU + other 
 
1.00 
1.15 (0.97 to 1.37) 
0.82 (0.56 to 1.02) 
 
 
0.1153 
0.2967 
 
1.00 
1.27 (1.06 to 1.52) 
1.03 (0.69 to 1.55) 
 
 
0.0099 
0.8698 
What is the client’s current housing status: homelessness 
Yes 
No 
 
1.31 (0.76 to 2.25) 
1.00 
 
0.3290 
  
Has the client used any of the drugs in the past 12 mo? 
Yes 
No 
 
1.19 (1.02 to 1.39) 
1.00 
 
0.0229 
  
Case assignment 
LTC OW 
Other AMTU staff 
Non-AMTU staff 
 
1.00 
1.27 (1.03 to 1.58) 
1.02 (0.76 to 1.36) 
 
 
0.0278 
0.8960 
 
 
 
 
Factors Associated With Rates of Engagement in Care 
 
Adolescents with a shorter time from HIV testing to referral (0–7, 8–14, and 15–28 days versus 
>365 days) were more likely to engage in care as were those with shorter time in days from 
referral to linkage to care (1–7 and 8–14 days versus 22–42 days) (Table 4). Individuals who 
self-identified as non-Hispanic and those assigned to non-AMTU staff compared with the 
linkage to care outreach worker were less likely to engage in care.20 
 
Table 4. Adjusted Relationship of Time in Days From Referral to Engagement-In-Care With 
Potential Impact Factors 
 AOR* (95% CI) P 
Days from HIV testing to referral 
0–7 
8–14 
15–28 
29–365 
365+ 
 
2391 (1.43 to 5.94) 
3.37 (1.25 to 9.07) 
3.61 (1.33 to 9.80) 
1.86 (0.92 to 3.74) 
1.00 
 
0.0033 
0.0164 
0.0115 
0.0834 
Days from referral to LTC 
0 
1–7 
8–14 
15–21 
22–42 
 
2.29 (0.98 to 5.37) 
2.01 (1.04 to 3.89) 
2.43 (1.13 to 5.27) 
1.32 (0.59 to 2.95) 
1.00 
 
0.0571 
0.0382 
0.0238 
0.4926 
Race/ethnicity 
Non-Hispanic white 
Non-Hispanic black 
Non-Hispanic other 
Hispanic 
 
1.00 
0.42 (0.10 to 1.82) 
0.17 (0.03 to 0.92) 
0.34 (0.07 to 1.59) 
 
 
0.2488 
0.0400 
0.1701 
Case assignment 
LTC OW 
Other AMTU staff 
Non-AMTU staff 
 
1.00 
0.75 (0.35 to 1.62) 
0.32 (0.15 to 0.70) 
 
 
0.4674 
0.0044 
*AOR, adjusted odds ratio 
 
DISCUSSION 
 
This study demonstrates that the time interval between a newly diagnosed adolescent's HIV test 
and care referral and the time interval between care referral and first medical visit (linkage to 
care) have concrete implications for long-term HIV care engagement. Specifically, the results 
show that the speed with which an adolescent is initially incorporated into the network of care 
services matters for engagement. Those who have shorter intervals between HIV test and 
referral, and referral to linkage, are more likely to quickly engage in care, and more successfully. 
 
These findings suggest that care engagement is the outcome of a process that begins very early in 
the HIV care continuum and may be influenced by factors other than support for adherence 
to HIV clinic appointments.21 These data have quality of care implications for HIV testing 
programs in that the speed with which HIV-positive youth are referred for linkage has 
downstream implications for engagement—a step in the HIV Care Continuum that is critical for 
initiation of ART and other prevention services.9 The data also support the importance in early, 
active patient engagement to reduce drop-out from care after initial linkage to care.22,23 
 
Our data also suggest that HIV care is truly a continuum, so that earlier outcomes may be 
important throughout the posttest period, not just through effects on the next immediate 
continuum milestone. Even if a youth does not immediately link, early referral and connection to 
clinic staff can help support eventual engagement.24 The findings also highlight which youth (ie, 
women, non-white youth, youth who acquired HIV through heterosexual sex) need additional 
support to be more quickly referred, linked, and eventually engaged in care. It also highlights the 
importance of where and to whom a youth is assigned to care. These data show that individuals 
who were assigned to AMTU staff were more likely to engage, yet those assigned to other 
AMTU staff (compared with the outreach worker) had shorter engagement intervals. Outreach 
workers were often assigned the youth with most challenging barriers, which often 
impacted time to linkage and engagement. This highlights the variation in needs of individual 
youth and the importance of clinical infrastructure with capacity to provide clinical care and 
wraparound services by staff dedicated to the linkage process. 
 
These findings are particularly meaningful because the HIV care continuum often depicts 
progress from HIV testing to care linkage and engagement as one step9,11; little attention has 
been given to the role of referral to care. Specifically, we found no research examining the length 
of the interval from HIV testing to referral, referral to linkage, or HIV testing to linkage and 
implications for care engagement with an ultimate goal of viral suppression. Irrespective of the 
strength of a care linkage system, an individual has to be tested and referred to care. These 
results demonstrate the important role timing plays in that initial step, suggesting the need for 
both a care linkage infrastructure and close collaborations between community-based 
organizations that provide testing, health departments, and adolescent medicine 
clinics.18Previous research25,26 has demonstrated how community mobilization can improve 
community networks, which in turn facilitate the pathways through which HIV testing occurs 
and referrals to linkage are made. This is particularly true as calls to “test and treat” expand and 
cause HIV testing to occur in more diverse venues, many of which may not have as much 
experience referring and linking individuals into care. The diversity of testing locations will also 
become more salient as testing expands into lower prevalence areas that may not have strong 
referral networks. Given that individuals tested in community venues take longer to refer and 
link to care,27 our work shows it is imperative to create an organized public health approach to 
facilitate individuals' pathway through the gaps in the care continuum between “test” and “treat” 
to improve engagement, and ultimately, viral suppression outcomes among HIV-infected youth. 
 
The study found that the referral and linkage infrastructure seem to work more successfully for 
certain populations of youth, whereas others take longer to link and engage and will require more 
resources to ensure that they do. Such discrepancies may exist given the demographics of the 
US HIV/AIDS epidemic. For example, clinics may tailor their services to men who have sex 
with men, making women or heterosexual men feel less welcome or less 
comfortable.24Adolescents in particular may also feel that accessing care does not outweigh the 
social risk of inadvertent disclosure or stigma. Such individuals should be the focus of future 
interventions to facilitate successful engagement for all youth. 
 
Providers described adolescents as frequently unwilling to accept their diagnoses or the level of 
clinical engagement their diagnosis would require. In such instances, providers advocated for 
other strategies (and the provision of wraparound services) to increase chances of eventual 
engagement. Many newly diagnosed adolescents refused to disclose to anybody because of a 
lack of family or community support; system fragmentation also compromises rapid linkage to 
care.28–30 However, such findings are complicated by these data that demonstrate the need to 
refer and link youth as quickly as possible. Being able to expedite the referral and linkage 
process for adolescents requires testing staff and providers with youth-focused skills and a 
network of clinics and community organizations that can assist them.24Studies have shown the 
individual and community-level implications of delayed care linkage; the relationship between 
rapid linkage and poorer engagement is likely because adolescents were still adjusting to their 
diagnoses, overwhelmed by the amount of medical information, and unsure of how to proceed or 
had insecurities in engaging with medical providers.20,21,24 This study demonstrates that the 
definition of care linkage as one visit within a period of time may be insufficient to help 
an adolescent stay on the care continuum and ultimately become engaged in care. More 
specifically, care linkage is not a single event that involves only a medical visit and a blood 
draw. Instead, it should be treated as part of a larger process that requires multiple medical and 
non-medical visits, phone calls, emails, and/or texts, even for those who are linked on the first 
day. It is important to refer and link each individual to care as quickly as possible after testing to 
increase the speed and likelihood of engagement, ART prescription, and ultimate health 
outcomes. 
 
Limitations 
 
Our study represents a large and comprehensive data set for care linkage and engagement 
for HIV-infected adolescents. HIV testing within communities, however, is neither systematic 
nor coordinated with mandated reporting. Such disjunctures often delayed a provider's ability to 
refer for care linkage by several months, and referral systems vary across the 15 ATN clinics. 
Referral bias is also possible: a small proportion (about 16%) of youth were already linked to 
care at the time of referral; these individuals were excluded from analysis. There were 
individuals who were not linked to care within 42 days and then re-entered into the database and 
linked to care during a second 42-day period; these individuals were duplicates and thus also 
excluded from the analyses. The ATN sites are all located in major urban metropolitan centers 
where the HIV epidemic is concentrated for youth and may not be generalizable to other settings 
in the United States. 
 
Conclusions 
 
This research demonstrated that only 62% of newly diagnosed HIV-positive adolescents are 
linked and engaged in care within 22 weeks of referral, and thus identify an additional point in 
the HIV care continuum that needs to be examined—the time between HIV testing and referral 
and referral and linkage—as predictive of care engagement. Indeed, this gap in the care 
continuum must be addressed in order for the United States to successfully address 
the HIV epidemic. Our research suggests that each newly diagnosed HIV-infected youth needs to 
be linked to care as quickly as possible to facilitate a more rapid engagement in care, access to 
medications, and better long-term prognosis. Intensive linkage-focused interventions could 
increase rapid engagement and thus medication initiation and viral suppression. This focus on 
rapid linkage, however, should also incorporate an assessment of whether an adolescent is 
actually ready to participate in care. Our results highlight ways to approach care for newly 
diagnosed adolescents that may facilitate improvements in how youth initiate a lifetime of care. 
The processes through which a newly diagnosed HIV-infected adolescent is identified, referred, 
linked, and engaged in care is often complex and requires coordination between health 
departments, community organizations, and national-level policy making. Accordingly, these 
data should be used to build evidence and help construct a seamless continuum of care for HIV-
infected youth to help fulfill the goals outlined in the US National HIV/AIDS Strategy. 
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